Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Dare Bioscience, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −1 vs. Q1 2025
- Shares held
- 904.3K
- +77.3K (+9.3%) vs. Q1 2025
- Total value
- $2.16M
- −$228.8K (−9.6%) vs. Q1 2025
- New holders
- 2
- 5 more added
- Sold out
- 3
- 5 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $2.75M |
| Q1 2026 | 25 | $1.87M |
| Q4 2025 | 27 | $1.90M |
| Q3 2025 | 21 | $2.12M |
| Q2 2025 | 23 | $2.16M |
| Q1 2025 | 24 | $2.39M |
| Q4 2024 | 25 | $2.43M |
| Q3 2024 | 22 | $2.08M |
| Q2 2024 | 28 | $2.46M |
| Q1 2024 | 36 | $3.35M |
| Q4 2023 | 35 | $2.04M |
| Q3 2023 | 30 | $5.97M |
| Q2 2023 | 28 | $5.92M |
| Q1 2023 | 29 | $7.16M |
| Q4 2022 | 30 | $5.82M |
| Q3 2022 | 31 | $7.56M |
| Q2 2022 | 36 | $9.12M |
| Q1 2022 | 40 | $9.89M |
| Q4 2021 | 38 | $13.7M |
| Q3 2021 | 37 | $8.07M |
| Q2 2021 | 34 | $6.40M |
| Q1 2021 | 30 | $6.10M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Dare Bioscience, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 328,328 | $784.7K | 0.00% | 00.0% | Unchanged |
| AMH Equity Ltd | 193,603 | $462.7K | 0.68% | +29,301+17.8% | Added |
| Susquehanna International Group, LLP | 106,887 | $255.5K | 0.00% | +48,723+83.8% | Added |
| Geode Capital Management, LLC | 95,455 | $228.2K | 0.00% | −450−0.5% | Reduced |
| Renaissance Technologies LLC | 71,795 | $171.6K | 0.00% | +1,200+1.7% | Added |
| State Street Corp | 23,515 | $56.2K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 16,971 | $40.6K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 16,735 | $40.0K | 0.00% | +50+0.3% | Added |
| UBS Group AG | 15,008 | $35.9K | 0.00% | −7,083−32.1% | Reduced |
| Northern Trust Corp | 14,970 | $35.8K | 0.00% | −74−0.5% | Reduced |
| Price T Rowe Associates Inc | 10,222 | $25.0K | 0.00% | −269−2.6% | Reduced |
| Global Retirement Partners, LLC | 4,359 | $10.4K | 0.00% | +4,359 | New |
| Raymond James Financial Inc | 1,684 | $4.03K | 0.00% | +1,684 | New |
| Allworth Financial LP | 1,667 | $3.98K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,440 | $3.44K | 0.00% | −2−0.1% | Reduced |
| Insight Financial Services | 950 | $2.27K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 575 | $1.37K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 99 | $236 | 0.00% | +12+13.8% | Added |
| EverSource Wealth Advisors, LLC | 42 | $100 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 17 | $41 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7 | $17 | 0.00% | 00.0% | Unchanged |
| Cornerstone Planning Group LLC | 2 | $5 | 0.00% | 00.0% | Unchanged |
| Putney Financial Group LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Mather Group, LLC. | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −19−100.0% | Sold out |